News & Analysis on Clinical Trial Services & Contract Research And Development
Danish company Novozymes announced yesterday that the US Department of Energy (DOE) has approved the third year of funding for Novozymes' three-year subcontract to develop more cost-efficient enzymes for ethanol production.
Isis Innovation, the wholly-owned technology transfer company of Oxford University, reports this week that researchers at the university's Inorganic Chemistry laboratory have found that they can intercalate a range of pharmaceutically active molecules...
US demand for combinatorial chemistry products and services is set to increase by more than twelve per cent annually to reach $4 billion (€3.7bn) in 2006, according to a new report from market analyst the Freedonia group.
Swiss pharmaceuticals company Roche yesterday said its vitamins and fine chemicals unit, recently sold to DSM, fully complies with new requirements for vitamin E issued this month by the Netherlands.
France needs to invest more in the emerging 'revolutionary' science of nanotechnologies if it is to remain competitive in this promising field, a French parliamentary committee has recommended.